| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.02B | -10.0% |
| Cost of Revenue | $563.2M | -11.9% |
| Gross Profit | $454.7M | -7.5% |
| R&D Expense | $105.5M | +8.9% |
| SG&A Expense | $70.3M | +6.9% |
| Operating Income | $210.8M | -20.7% |
| Pre-tax Income | $230.3M | -17.3% |
| Income Tax | $29.3M | -9.4% |
| Net Income | $201.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.5M | -26.2% |
| Short-term Investments | $447.8M | +32.2% |
| Accounts Receivable | $203.1M | -6.8% |
| Inventory | $282.2M | -7.9% |
| Current Assets | $1.12B | +4.0% |
| Total Assets | $1.35B | +5.2% |
| Current Liabilities | $207.5M | -27.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $140.8M | -10.2% |
| Capital Expenditures | $12.2M | -41.0% |
| Investing Cash Flow | -$108.7M | -7.8% |
| Financing Cash Flow | -$71.2M | -4.3% |
| Free Cash Flow | $128.6M | -5.6% |
| -18.4% |
| EPS (Basic) | $6.17 | -18.0% |
| EPS (Diluted) | $6.15 | -17.2% |
| Total Liabilities |
| $336.0M |
| -19.4% |
| Stockholders' Equity | $1.01B | +17.1% |